VORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Vor Biopharma Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$18.04+0.01 (+0.06%)
Close on Oct 19, 2026
- Market cap
- $979.65M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$10.96 (−37.79%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $979.65M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -14.37%
Fundamentals
- Net income
- $627.78M
- EPS, diluted
- -$70.50
- Free cash flow
- -$140.81M
- Book value per share
- -$3.69
- Diluted shares
- 54M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Operating income
-$147.08M
Net income
$627.78M
EPS, diluted
–
Free cash flow
-$140.81M
Reported periodTrailing twelve months